AMANDA MARTIN: Open Payments
NPI 1194144352 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,172 in 116 payments from 40 companies in 2025. Trend: 2023 $474 · 2024 $1,970 · 2025 $3,172
Food & beverage: $2,382Long term medical supply or device loan: $598Education: $192
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $758 |
| Merck Sharp & Dohme LLC | 9 | $232 |
| Janssen Biotech, Inc. | 5 | $219 |
| E.R. Squibb & Sons, L.L.C. | 9 | $149 |
| Celgene Corporation | 10 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $126 |
| Genentech USA, Inc. | 5 | $108 |
| SEAGEN INC. | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| BeOne Medicines USA, Inc. | 4 | $86 |
Products named: KISQALI, KEYTRUDA, REBLOZYL, LIBTAYO, ERLEADA, BRUKINSA, CABOMETYX, SCEMBLIX.
Industry payments across TN — which companies pay providers there.
